NF1 has recently been recognised as the third most commonly mutated gene (after BRAF and RAS) in cutaneous melanoma, activating the MAP kinase pathway.11 In our conjunctival melanoma cohort, NF1 mutations were also present in samples harbouring activating RAS or BRAF mutations (Fig. 1). Here, BRAF is linked to cutaneous melanoma.